Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2010
06/17/2010US20100152253 Non-steroidal brassinosteroid mimetic
06/17/2010US20100152252 Heterocyclyl-substituted-ethylamino-phenyl derivatives, their preparation and use as medicaments
06/17/2010US20100152251 Pyridine, quinoline, and isoquinoline n-oxides as kinase inhibitors
06/17/2010US20100152250 Capsule formulation of pirfenidone and pharmaceutically acceptable excipients
06/17/2010US20100152249 Compositons and method for treatment of mood and cognitive impairments
06/17/2010US20100152248 Ischemic disorder or disease inhibitors
06/17/2010US20100152247 medicament for treating schizophrenia comprising cilostazol
06/17/2010US20100152246 5-Oxoisoxazoles as inhibitors of lipases and phospholipases
06/17/2010US20100152244 Self-emulsifying formulation of tipranavir for oral administration
06/17/2010US20100152243 Treatment of renal cell carcinoma
06/17/2010US20100152242 Transdermal Electrotransport Delivery Device Including an Antimicrobial Compatible Reservoir Composition
06/17/2010US20100152241 Inhibitors of store operated calcium release
06/17/2010US20100152240 Pyrroline-2-one derivatives against cell releasing tumor necrosis factor, preparation methods and uses thereof
06/17/2010US20100152239 Method to Improve Survival in Sepsis
06/17/2010US20100152238 Novel quinonoid derivatives of cannabinoids and their use in the treatment of malignancies
06/17/2010US20100152237 Bis-pyrindino containing compounds for the use in the treatment of cns pathologies
06/17/2010US20100152236 Cyclic amine compound
06/17/2010US20100152235 Oxadiazole derivatives active on sphingosine-1-phosphate (s1p)
06/17/2010US20100152234 Substituted 4-(1,2,3,4-tetrahydroisoquinolin-2-yl)-4-oxobutyric acid amide as KCNQ2/3 modulators
06/17/2010US20100152233 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
06/17/2010US20100152232 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
06/17/2010US20100152231 Compositions Useful For Treating Irritable Bowel Syndrome
06/17/2010US20100152230 Hydroxy substituted 1h-imidazopyridines and methods
06/17/2010US20100152229 Process for the Synthesis of Moxifloxacin Hydrochloride
06/17/2010US20100152228 Pharmaceutical compositions and methods for relieving pain and treating central nervous system disorders
06/17/2010US20100152227 Methods for Enhancing Stability of Polyorthoesters and Their Formulations
06/17/2010US20100152226 Sustained release implant for granisetron
06/17/2010US20100152225 Hydrogenated pyrido [4,3-b] indoles such as dimebon for treating canine cognitive dysfunction syndrome
06/17/2010US20100152224 Scopine modulators of muscarinic acetylcholine receptor
06/17/2010US20100152223 Crystal form of cabergoline
06/17/2010US20100152222 Medicinal Compositions Comprising Buprenorphine And Nalmefene
06/17/2010US20100152221 Pharmaceutical composition
06/17/2010US20100152220 Indene derivatives as pharmaceutical agents
06/17/2010US20100152219 Pyrazole derivatives as inhibitors of receptor tyrosine kinases
06/17/2010US20100152218 Compositions and methods for inhibition of the jak pathway
06/17/2010US20100152217 Method for treating a pulmonary hypertension condition
06/17/2010US20100152216 Monocyclic anilide spirolactam cgrp receptor antagonists
06/17/2010US20100152215 Methods of identifying activators of lyn kinase
06/17/2010US20100152214 Novel pyrimidinecarboxamide derivatives
06/17/2010US20100152213 Compound that is a dual inhibitor of enzymes pde7 and/or pde4, pharmaceutical compositions and uses thereof
06/17/2010US20100152212 Preq1 riboswitches and methods and compositions for use of and with preq1 riboswitches
06/17/2010US20100152211 Inhibitors of human phosphatidylinositol 3-kinase delta
06/17/2010US20100152210 Purinyl derivatives and their use as potassium channel modulators
06/17/2010US20100152209 Compounds for Modulating TRPV3 Function
06/17/2010US20100152208 Bicyclic heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
06/17/2010US20100152207 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
06/17/2010US20100152206 Bicyclic Dihydropyrimidines and Uses Thereof
06/17/2010US20100152205 Cxcr2 inhibitors
06/17/2010US20100152204 Treatment for spinal muscular atrophy
06/17/2010US20100152203 Thiadiazole-substituted arylamides as p2x3 and p2x2/3 antagonists
06/17/2010US20100152202 Tissue Factor Promoter Polymorphisms
06/17/2010US20100152201 Oligomer-Antihistamine Conjugates
06/17/2010US20100152200 Alphavirus inhibitors and uses thereof
06/17/2010US20100152199 Heteroarylalkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists
06/17/2010US20100152198 Use of c-src inhibitors in combination with a pyrimidylaminobenzamide compound for the treatment of leukemia
06/17/2010US20100152197 (4-tert-butylpiperazin-2-yl)(piperazin-1-yl)methanone-n-carboxamide derivatives
06/17/2010US20100152196 Novel Fused Pyrrolocarbazoles
06/17/2010US20100152195 Azabicyclo (3.1.0) Hexane Derivatives Useful As Modulators Of Dopamine D3 Receptors
06/17/2010US20100152193 Pyridazinones
06/17/2010US20100152192 Fused imidazole carboxamides as trpv3 modulators
06/17/2010US20100152191 Cyclopropyl pyrrolidine orexin receptor antagonists
06/17/2010US20100152190 Substituted Pyrrolidine-2-Carboxamides
06/17/2010US20100152189 Novel polymorphous form and the amorphous form of 5-chloro-n-({ (5s)-2-oxo-3[4-(3-oxo-4-morpholinyl(-phenyl]-1,3-oxazolidine-5-yl}-methyl)-2-thiophene carboxamide
06/17/2010US20100152188 Novel Heterocyclic Compounds
06/17/2010US20100152187 Aminothiazole derivatives as human stearoyl-coa desaturase inhibitors
06/17/2010US20100152186 Triazolyl pyridyl benzenesulfonamides
06/17/2010US20100152185 Diphenyl substituted cycloalkanes, compositions containing such compounds and methods of use
06/17/2010US20100152184 Pharmaceutical compounds
06/17/2010US20100152183 Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
06/17/2010US20100152182 2,4- Di(hetero)-arylamino-pyrimidine Derivatives as ZAP-70 and/or SYK inhibitors
06/17/2010US20100152181 Amino pyrazole compound
06/17/2010US20100152180 4-oxo-4,5-dihydropyrrolo[1,2-A)quinoxaline derivatives as inhibitors of poly(ADP-ribose) polymerase (PARP)
06/17/2010US20100152179 Treatment of central nervous system disorders
06/17/2010US20100152178 Imidazole derivatives
06/17/2010US20100152177 Compounds having 5-ht6 receptor affinity
06/17/2010US20100152176 Modulators of Muscarinic Receptors
06/17/2010US20100152175 Pyridine Derivatives and Their Use in The Treatment of Psychotic Disorders
06/17/2010US20100152174 Macrocyclic quinazole derivatives and their use as mtki
06/17/2010US20100152173 Tablet Having Improved Stability With At Least Two Actives
06/17/2010US20100152172 2,4-pyrimidinediamine compounds for treating or preventing autoimmune diseases
06/17/2010US20100152171 CGRP Antagonists
06/17/2010US20100152170 Benzazole Derivatives, Compositions, And Methods Of Use As Aurora Kinase Inhibitors
06/17/2010US20100152169 4-oxoquinazolin-3-yl benzamide derivatives for the treatment of cytokine diseases
06/17/2010US20100152168 Substituted benzimidazolone derivatives, medicaments comprising them and their use
06/17/2010US20100152167 Pyrimidine derivatives
06/17/2010US20100152166 Compounds and methods for modulating fxr
06/17/2010US20100152165 Carboxylic acid derivatives
06/17/2010US20100152164 Method For Stabilizing Anti-Dementia Drug
06/17/2010US20100152163 Azepino[4,5-b]indoles and methods of use
06/17/2010US20100152162 Therapeutic and/or preventive agents for a sleep disorder
06/17/2010US20100152161 Compositions for weight management
06/17/2010US20100152160 Novel benzodioxane and benzoxazine derivatives useful as cc chemokine receptor ligands
06/17/2010US20100152159 Imidazopyrazine syk inhibitors
06/17/2010US20100152158 Substituted Disulfonamide Compounds
06/17/2010US20100152157 6-CYCLOAMINO-3-(PYRIDAZIN-4-YL)IMIDAZO[1,2-b]-PYRIDAZINE AND DERIVATIVES THEREOF PREPARATION AND THERAPEUTIC APPLICATION THEREOF
06/17/2010US20100152156 2-Azetidinone Derivatives For The Treatment Of Hyperlipidaemic Diseases
06/17/2010US20100152155 Histone Deacetylase Inhibitors
06/17/2010US20100152154 Novel platinum compounds for treating cancer
06/17/2010US20100152153 Nitric Oxide Releasing Compounds
06/17/2010US20100152152 Therapeutic Use of Nefopam
1 ... 2216 2217 2218 2219 2220 2221 2222 2223 2224 2225 2226 2227 2228 2229 2230 2231 2232 2233 2234 2235 2236 ... 7860